Form 8-K - Current report:
SEC Accession No. 0001628280-26-034834
Filing Date
2026-05-14
Accepted
2026-05-14 08:48:56
Documents
15
Period of Report
2026-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20260514.htm   iXBRL 8-K 29326
2 EX-99.1 ex991sntiq126earningsrelea.htm EX-99.1 60339
3 EX-99.2 ex992sntifdameeting20260514.htm EX-99.2 30721
7 picture2.gif GRAPHIC 18816
8 senti_logoxpra.jpg GRAPHIC 3383
  Complete submission text file 0001628280-26-034834.txt   290660

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20260514.xsd EX-101.SCH 1785
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20260514_lab.xml EX-101.LAB 22530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20260514_pre.xml EX-101.PRE 13045
18 EXTRACTED XBRL INSTANCE DOCUMENT snti-20260514_htm.xml XML 3038
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030
Senti Biosciences Holdings, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 26976053
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)